BURLINGTON, Mass. and JERUSALEM, Feb. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present and participate in one-on-one investor meetings at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Event: BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Date: Tuesday, February 15 – Thursday, February 17, 2022 Fireside Chat: Tuesday, February 15, 2022, at 9:30am ET Management will also meet with investors during the event. Investors interested in meeting with the BrainsWay management team during the conference should contact their BTIG representative.